ArticleThe oncologist2023

Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.

Haoran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.